论文部分内容阅读
目的:观察分析新活素治疗失代偿性心衰合并肺动脉高压的效果.方法:随机选取2016年5月-2018年5月期间我院收治的60例失代偿性心衰合并肺动脉高压患者作为本次观察对象,将其按入院顺序分成观察组30例和对照组30例,两组患者均给予临床常规治疗,同时给予对照组多巴酚丁胺与西地那非治疗,给予观察组患者新活素治疗,并对两组治疗效果进行对比分析.结果:治疗后观察组患者的后患者心率、呼吸频率、肺动脉收缩压及NT-proBNP等均得到明显改善,其数据结果与对照组相比差异较为明显,存在统计学意义(P<0.05);同时观察组患者临床治效果也显著高于对照组,两组间数据差距较为显著,具有可比性(P<0.05).结论:针对失代偿性心衰合并肺动脉高压患者采用新活素治疗,可有效提高临床治疗效果,改善患者临床症状,建议临床广泛推广和应用.“,”Objective:To observe and analyze the effect of Xin Huo Su in the treatment of decompensated heart failure complicated with pulmonary hypertension.Methods:60 patients with decompensated heart failure combined with pulmonary hypertension were selected randomly in our hospital during the period of May-2018 May 2016.The patients were divided into observation group(30 cases)and control group(30cases)according to the order of admission.The two groups were given clinical routine treatment,and the control group was given dobutamine and sildenafil.The patients in the observation group were treated with Xin Huo Su,and the therapeutic effects of the two groups were compared and analyzed.Results:after treatment,the heart rate,respiratory frequency,pulmonary systolic pressure and NT-proBNP of the patients in the observation group were significantly improved.The data were significantly different from those in the control group(P<0.05),and the clinical effect of the observation group was significantly higher than that of the control group,and the data between the two groups were poor.The distance is more significant and has comparability(P<0.05).Conclusion:the use of new living hormone therapy in patients with decompensated heart failure combined with pulmonary hypertension can effectively improve the effect of clinical treatment and improve the clinical symptoms of the patients.It is suggested that the clinical widely spread and application.